NYSE: GKOS - Glaukos Corporation

Yield per half year: -34.62%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Glaukos Corporation

Extended chart Simple chart
Financial Markets by TradingView

About Glaukos Corporation

Glaukos Corporation, офтальмологическая, медицинская и фармацевтическая компания, специализируется на разработке новых методов лечения глаукомы, заболеваний роговицы и сетчатки. Он предлагает микро-обходные стенты iStent, iStent inject, iStent inject W, которые усиливают отток водянистой влаги, вставленные при хирургии катаракты для лечения открытоугольной глаукомы легкой и средней степени тяжести.

more details
Ассортимент продукции компании включает iStent Infinite для использования в качестве отдельной процедуры у пациентов с рефрактерной глаукомой; iStent SA, продукт с двумя стентами, разработанный для использования в качестве автономной процедуры глаукомы; и iDose TR, целевой инъекционный имплантат, основанный на микромасштабной платформе устройства, который предназначен для доставки лекарств на терапевтических уровнях. Компания продает свою продукцию через организацию прямых продаж, а также через дистрибьюторов в США и за рубежом. Корпорация Glaukos была зарегистрирована в 1998 году, ее штаб-квартира находится в Сан-Клементе, Калифорния.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2015-06-25
ISIN US3773221029
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.glaukos.com
Цена ао 93.66
Change price per day: -1.04% (94.64)
Change price per week: +7.4% (87.2)
Change price per month: +3.98% (90.07)
Change price per 3 month: -35.56% (145.34)
Change price per half year: -34.62% (143.25)
Change price per year: -13.57% (108.36)
Change price per 3 year: +128.43% (41)
Change price per 5 year: +114.46% (43.67)
Change price per year to date: -38.66% (152.67)
All parameters

Underestimation

Title Value Grade
P/S 20.57 1
P/BV 10.28 1
P/E 0 0
EV/EBITDA -100.75 0
Total: 1.5

Efficiency

Title Value Grade
ROA, % -15.29 0
ROE, % -23.83 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 1.43

Debt

Title Value Grade
Debt/EBITDA -1.33 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % 70.44 8
Yield Ebitda, % -7.13 0
Yield EPS, % 2.76 1
Total: 4.6
More

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
25.03.2025 27.03.2025 Thurman Alex R.
SVP & CHIEF FINANCIAL OFFICER		 Sale 106.84 162 397 1520 0 0 link
11.12.2024 13.12.2024 Kliman Gilbert H
Director		 Sale 144.01 288 020 2000 0 0 link
11.12.2024 13.12.2024 Kliman Gilbert H
Director		 Purchase 32 64 000 2000 0 0 link
09.09.2024 11.09.2024 Kliman Gilbert H
Director		 Sale 130.67 392 010 3000 0 -0.01 link
09.09.2024 11.09.2024 Kliman Gilbert H
Director		 Purchase 32 96 000 3000 0 0.01 link
15.08.2024 15.08.2024 Stapley Marc
Director		 Purchase 125.93 787 063 6250 0 0.01 link
05.07.2024 09.07.2024 Gilliam Joseph E
PRESIDENT & COO		 Sale 121.39 273 128 2250 0 0 link
05.07.2024 09.07.2024 Gilliam Joseph E
PRESIDENT & COO		 Purchase 69.3 155 925 2250 0 0 link
15.05.2024 16.05.2024 Stapley Marc
Director		 Sale 112.8 705 000 6250 0 -0.01 link
15.05.2024 16.05.2024 Stapley Marc
Director		 Purchase 32 200 000 6250 0 0.01 link
10.04.2024 12.04.2024 Hoffmeister David F
Director		 Purchase 7.28 72 800 10000 0 0.02 link
08.04.2024 10.04.2024 Gilliam Joseph E
PRESIDENT & COO		 Sale 100.47 6 008 210 59801 0 -0.13 link
08.04.2024 10.04.2024 Gilliam Joseph E
PRESIDENT & COO		 Purchase 41.69 2 493 100 59801 0 0.13 link
08.04.2024 09.04.2024 Thurman Alex R.
SVP & CHIEF FINANCIAL OFFICER		 Sale 100.54 137 941 1372 0 0 link
05.04.2024 09.04.2024 Gilliam Joseph E
PRESIDENT & COO		 Sale 96.81 237 862 2457 0 -0.01 link
05.04.2024 09.04.2024 Gilliam Joseph E
PRESIDENT & COO		 Purchase 55.18 135 577 2457 0 0.01 link
05.04.2024 09.04.2024 Thurman Alex R.
SVP & CHIEF FINANCIAL OFFICER		 Sale 96.63 25 317 262 0 0 link
29.02.2024 04.03.2024 Stapley Marc
Director		 Sale 90.09 563 063 6250 0 -0.01 link
09.02.2024 12.02.2024 Gilliam Joseph E
PRESIDENT & COO		 Sale 96.7 61 018 631 0 0 link
08.02.2024 09.02.2024 Thurman Alex R.
SVP & CHIEF FINANCIAL OFFICER		 Sale 95.78 52 679 550 0 0 link
07.02.2024 09.02.2024 Thurman Alex R.
SVP & CHIEF FINANCIAL OFFICER		 Sale 95 3 135 33 0 0 link
22.01.2024 24.01.2024 Gilliam Joseph E
PRESIDENT & COO		 Sale 94.01 49 261 524 0 0 link
22.01.2024 24.01.2024 Gilliam Joseph E
PRESIDENT & COO		 Purchase 39.1 20 488 524 0 0 link
14.07.2023 18.07.2023 Burns Thomas William
CHAIRMAN & CEO		 Sale 77.95 2 338 500 30000 0 -0.06 link
14.07.2023 18.07.2023 Burns Thomas William
CHAIRMAN & CEO		 Purchase 7.28 218 400 30000 0 0.06 link
10.07.2023 11.07.2023 Burns Thomas William
CHAIRMAN & CEO		 Sale 70.87 952 493 13440 0 -0.03 link
10.07.2023 11.07.2023 Burns Thomas William
CHAIRMAN & CEO		 Purchase 7.28 97 843 13440 0 0.03 link
07.07.2023 11.07.2023 Burns Thomas William
CHAIRMAN & CEO		 Sale 70 9 310 133 0 0 link
07.07.2023 11.07.2023 Burns Thomas William
CHAIRMAN & CEO		 Purchase 7.28 968 133 0 0 link
28.06.2023 30.06.2023 Burns Thomas William
CHAIRMAN & CEO		 Sale 70.19 1 881 790 26810 0 -0.06 link
28.06.2023 30.06.2023 Burns Thomas William
CHAIRMAN & CEO		 Purchase 7.28 195 177 26810 0 0.06 link
18.05.2023 19.05.2023 Burns Thomas William
CHAIRMAN & CEO		 Sale 60.17 701 703 11662 0 -0.02 link
18.05.2023 19.05.2023 Burns Thomas William
CHAIRMAN & CEO		 Purchase 7.28 84 899 11662 0 0.02 link
17.05.2023 19.05.2023 Burns Thomas William
CHAIRMAN & CEO		 Sale 60.04 37 225 620 0 0 link
17.05.2023 19.05.2023 Burns Thomas William
CHAIRMAN & CEO		 Purchase 7.28 4 514 620 0 0 link

Institutions Volume Share, %
Blackrock Inc. 7894315 15.96
FMR, LLC 5819110 11.76
Vanguard Group Inc 5236738 10.59
Brown Capital Management, LLC 2697794 5.45
State Street Corporation 1816911 3.67
Fred Alger Management, LLC 1645081 3.33
Janus Henderson Group PLC 1616534 3.27
Invesco Ltd. 1572615 3.18
Wellington Management Group, LLP 1340500 2.71
Artisan Partners Limited Partnership 1222916 2.47

ETF Share, % Profitability for 1 year, % Dividends, %
iShares Morningstar Small-Cap Growth ETF 0.28929 3.67 0.72598
iShares Morningstar Small-Cap ETF 0.1454 391.25 1.60498
Syntax Stratified SmallCap ETF 0.11075 13.51 1.639



Head Job title Payment Year of birth
Mr. Thomas William Burns Chairman & CEO 1.5M 1961 (64 years)
Mr. Joseph E. Gilliam President & COO 974.59k 1976 (49 years)
Mr. Chris M. Calcaterra Executive Vice President of Global Commercial Operations 198.66k 1960 (65 years)
Dr. Mory Gharib Ph.D. Co-Founder N/A
Mr. Christopher William Lewis Vice President of Investor Relations & Corporate Affairs N/A
Ms. Michele M. Allegretto Senior Vice President of Human Resources N/A
Ms. Diana A. Scherer VP of Compliance & Deputy General Counsel N/A
Mr. Alex R. Thurman Senior VP & CFO 373.4k 1970 (55 years)
Dr. Tomas Navratil Ph.D. Chief Development Officer 721.51k 1977 (48 years)
Ms. Jane E. Rady Senior Vice President of Corporate Strategy & Business Development N/A 1948 (77 years)

Address: United States, San Clemente, 229 Avenida Fabricante - open in Google maps, open in Yandex maps
Website: http://www.glaukos.com